The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting α-ketoglutarate to 2-hydroxyglutarate - Ward, P S; Patel, J; Wise, D R (Cancer cell, 2010)
et al.